{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:25:35Z","timestamp":1787318735338,"version":"build-2736575974"},"reference-count":52,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1097\/iae.0b013e31816079e8","type":"journal-article","created":{"date-parts":[[2008,7,10]],"date-time":"2008-07-10T09:47:35Z","timestamp":1215683255000},"page":"573-580","source":"Crossref","is-referenced-by-count":62,"title":["SECONDARY OCULAR HYPERTENSION AFTER INTRAVITREAL INJECTION OF 4 MG OF TRIAMCINOLONE ACETONIDE"],"prefix":"10.1097","volume":"28","author":[{"given":"DANIEL V.","family":"VASCONCELOS-SANTOS","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PATR\u00cdCIA G.","family":"NEHEMY","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ANDREW P.","family":"SCHACHAT","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00c1RCIO B.","family":"NEHEMY","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20210130","first-page":"198","article-title":"Intraocular pressure response to topical corticosteroids.","volume":"26","author":"Becker","year":"1965","journal-title":"Invest Ophthalmol"},{"key":"R2-8-20210130","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1089\/jop.1993.9.35","article-title":"Identification of high intraocular pressure responders to topical ophthalmic corticosteroids.","volume":"9","author":"Bartlett","year":"1993","journal-title":"J Ocul Pharmacol"},{"key":"R3-8-20210130","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.jaci.2005.07.031","article-title":"Discontinuing nasal steroids might lower intraocular pressure in glaucoma.","volume":"116","author":"Bui","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"R4-8-20210130","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.preteyeres.2005.01.004","article-title":"Intravitreal triamcinolone acetonide for treatment of intraocular proliferative, exudative, and neovascular diseases.","volume":"24","author":"Jonas","year":"2005","journal-title":"Prog Retin Eye Res"},{"key":"R5-8-20210130","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1046\/j.1440-1606.1999.00238.x","article-title":"Intravitreal triamcinolone and elevated intraocular pressure.","volume":"27","author":"Wingate","year":"1999","journal-title":"Aust NZ J Ophthalmol"},{"key":"R6-8-20210130","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1046\/j.1442-9071.2001.00360.x","article-title":"Safety and efficacy of intravitreal triamcinolone for cystoid macular oedema in uveitis.","volume":"29","author":"Young","year":"2001","journal-title":"Clin Exp Ophthalmol"},{"key":"R7-8-20210130","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00347-003-0975-z","article-title":"Ocular side effects and complications of intravitreal triamcinolone injection.","volume":"101","author":"Jaissle","year":"2004","journal-title":"Ophthalmologe"},{"key":"R8-8-20210130","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1001\/archopht.122.3.336","article-title":"Safety of an intravitreal injection of triamcinolone.","volume":"122","author":"Gillies","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"R9-8-20210130","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0008-4182(05)80119-X","article-title":"Complications of intravitreal injection of triamcinolone acetonide.","volume":"40","author":"Ozkiris","year":"2005","journal-title":"Can J Ophthalmol"},{"key":"R10-8-20210130","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.ajo.2005.11.050","article-title":"Cataract formation and other complications of intravitreal triamcinolone for macular edema.","volume":"141","author":"Thompson","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"R11-8-20210130","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/sj.eye.6702416","article-title":"Ocular morbidity associated with intravitreal triamcinolone acetonide.","volume":"21","author":"Konstantopoulos","year":"2007","journal-title":"Eye"},{"key":"R12-8-20210130","first-page":"32","article-title":"Efeito da triancinolona intrav\u00edtrea na press\u00e3o intra-ocular.","volume":"64","author":"Vasconcelos-Santos","year":"2005","journal-title":"Rev Bras Oftalmol"},{"key":"R13-8-20210130","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1136\/bjo.2006.093310","article-title":"The problem of pressure elevation associated with intravitreal triamcinolone.","volume":"90","author":"Conway","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"R14-8-20210130","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.ajo.2004.06.067","article-title":"Intravitreal triamcinolone acetonide and intraocular pressure.","volume":"138","author":"Smithen","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"R15-8-20210130","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3341\/kjo.2005.19.2.122","article-title":"Intraocular pressure elevation after intravitreal triamcinolone acetonide injection.","volume":"19","author":"Park","year":"2005","journal-title":"Korean J Ophthalmol"},{"key":"R16-8-20210130","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.ophtha.2004.10.042","article-title":"Intraocular pressure elevation after intravitreal triamcinolone acetonide injection.","volume":"112","author":"Jonas","year":"2005","journal-title":"Ophthalmology"},{"key":"R17-8-20210130","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1136\/bjo.2006.090340","article-title":"Intraocular pressure alterations following intravitreal triamcinolone acetonide.","volume":"90","author":"Rhee","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"R18-8-20210130","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1001\/archopht.117.10.1329","article-title":"Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials\u2014TAP report 1.","volume":"117","year":"1999","journal-title":"Arch Ophthalmol"},{"key":"R19-8-20210130","article-title":"SPSS for Windows [computer program], Version 12.","year":"2004"},{"key":"R20-8-20210130","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1350-9462(98)00035-4","article-title":"Effects of glucocorticoids on the trabecular meshwork: towards a better understanding of glaucoma.","volume":"18","author":"Wordinger","year":"1999","journal-title":"Prog Retin Eye Res"},{"key":"R21-8-20210130","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/00061198-200604000-00007","article-title":"Ultrastructure of the trabecular meshwork in secondary glaucoma eyes after intravitreal triamcinolone acetonide.","volume":"15","author":"Kubota","year":"2006","journal-title":"J Glaucoma"},{"key":"R22-8-20210130","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ajo.2004.03.001","article-title":"Early rapid rise in intraocular pressure after intravitreal triamcinolone acetonide injection.","volume":"138","author":"Singh","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"R23-8-20210130","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.ajo.2004.10.023","article-title":"Intraocular pressure rise after intravitreal triamcinolone.","volume":"139","author":"Vedantham","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"R24-8-20210130","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0002-9394(14)73759-6","article-title":"The effects of posterior subtenon injection of triamcinolone acetonide in patients with intermediate uveitis.","volume":"120","author":"Helm","year":"1995","journal-title":"Am J Ophthalmol"},{"key":"R25-8-20210130","first-page":"1048","article-title":"Intraocular pressure elevation after subtenon injection of triamcinolone acetonide during uveitis.","volume":"25","author":"Bui Quoc","year":"2002","journal-title":"J Fr Ophtalmol"},{"key":"R26-8-20210130","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1590\/S0004-27492003000300006","article-title":"Efeitos da inje\u00e7\u00e3o subtenoniana posterior de cortic\u00f3ide em pacientes com uve\u00edte.","volume":"66","author":"Finamor","year":"2003","journal-title":"Arq Bras Oftalmol"},{"key":"R27-8-20210130","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/00006982-200003000-00004","article-title":"Intravitreal triamcinolone acetonide in exudative age-related macular degeneration.","volume":"20","author":"Danis","year":"2000","journal-title":"Retina"},{"key":"R28-8-20210130","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3928\/1542-8877-20030901-08","article-title":"The effect of intravitreal triamcinolone acetonide on intraocular pressure.","volume":"34","author":"Bakri","year":"2003","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"R29-8-20210130","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1136\/bjo.87.1.24","article-title":"Intraocular pressure after intravitreal injection of triamcinolone acetonide.","volume":"87","author":"Jonas","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"R30-8-20210130","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.ajo.2004.12.087","article-title":"Intravitreal versus retrobulbar injections of triamcinolone for macular edema associated with branch retinal vein occlusion.","volume":"139","author":"Hayashi","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"R31-8-20210130","doi-asserted-by":"crossref","first-page":"1916e1","DOI":"10.1016\/j.ophtha.2005.06.009","article-title":"Outcome of intravitreal triamcinolone in uveitis.","volume":"112","author":"Kok","year":"2005","journal-title":"Ophthalmology"},{"key":"R33-8-20210130","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1442-9071.2006.01103.x","article-title":"Intravitreal triamcinolone injection for chronic diffuse diabetic macular oedema.","volume":"34","author":"Avci","year":"2006","journal-title":"Clin Exp Ophthalmol"},{"key":"R34-8-20210130","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.ophtha.2005.03.008","article-title":"Glaucoma and intravitreal steroids.","volume":"112","author":"Jampol","year":"2005","journal-title":"Ophthalmology"},{"key":"R35-8-20210130","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/01.ijg.0000151880.22479.d7","article-title":"Intravitreal triamcinolone acetonide and secondary ocular hypertension.","volume":"14","author":"Jonas","year":"2005","journal-title":"J Glaucoma"},{"key":"R36-8-20210130","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.ajo.2004.05.031","article-title":"Vitrectomy as a treatment for elevated intraocular pressure following intravitreal injection of triamcinolone acetonide.","volume":"138","author":"Agrawal","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"R37-8-20210130","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.ajo.2004.10.025","article-title":"Management of intractable glaucoma following intravitreal triamcinolone acetonide.","volume":"139","author":"Agrawal","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"R38-8-20210130","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ophtha.2005.10.021","article-title":"Intravitreal triamcinolone and IOP.","volume":"113","author":"Agrawal","year":"2006","journal-title":"Ophthalmology"},{"key":"R39-8-20210130","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1001\/archopht.124.1.133","article-title":"Argon laser trabeculoplasty for intractable glaucoma following intravitreal triamcinolone.","volume":"124","author":"Viola","year":"2006","journal-title":"Arch Ophthalmol"},{"key":"R40-8-20210130","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.ajo.2005.02.046","article-title":"Intravitreal triamcinolone acetonide may increase the intraocular pressure even in vitrectomized eyes after more than 3 months.","volume":"140","author":"Meyer","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"R41-8-20210130","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1136\/bjo.2005.088278","article-title":"Photographic estimation of the duration of high dose intravitreal triamcinolone in the vitrectomised eye.","volume":"90","author":"Kosobucki","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"R42-8-20210130","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0161-6420(02)01969-3","article-title":"Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection.","volume":"110","author":"Beer","year":"2003","journal-title":"Ophthalmology"},{"key":"R43-8-20210130","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.ajo.2003.08.012","article-title":"Intraocular availability of triamcinolone acetonide after intravitreal injection.","volume":"137","author":"Jonas","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"R44-8-20210130","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ajo.2004.02.025","article-title":"Duration of the effect of intravitreal triamcinolone acetonide as treatment for diffuse diabetic macular edema.","volume":"138","author":"Jonas","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"R45-8-20210130","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.ajo.2006.02.014","article-title":"LXII Edward Jackson lecture: open angle glaucoma after vitrectomy.","volume":"141","author":"Chang","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"R46-8-20210130","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/S0161-6420(03)00544-X","article-title":"Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization.","volume":"110","author":"Spaide","year":"2003","journal-title":"Ophthalmology"},{"key":"R47-8-20210130","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.ajo.2005.11.058","article-title":"Verteporfin and intravitreal triamcinolone acetonide combination therapy for occult choroidal neovascularization in age-related macular degeneration.","volume":"141","author":"Augustin","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"R48-8-20210130","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.ajo.2006.01.081","article-title":"Paracentesis before or after intravitreal injection of triamcinolone acetonide and its necessity?","volume":"141","author":"Lin","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"R49-8-20210130","first-page":"1","article-title":"Vitreous prolapse and IOL dislocation during intravitreal injection of triamcinolone acetonide.","volume":"20","author":"Degenring","year":"2005","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R50-8-20210130","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1055\/s-2005-858459","article-title":"Variations in intraocular pressure (IOP) and necessity for paracentesis following intravitreal triamcinolone injection.","volume":"222","author":"Dwinger","year":"2005","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"R51-8-20210130","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.ophtha.2005.10.061","article-title":"Short-term course of intraocular pressure after intravitreal injection of triamcinolone acetonide.","volume":"113","author":"Benz","year":"2006","journal-title":"Ophthalmology"},{"key":"R52-8-20210130","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.ajo.2004.01.028","article-title":"Vitreous wick syndrome: a potential cause of endophthalmitis after intravitreal injection of triamcinolone through the pars plana.","volume":"137","author":"Chen","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"R53-8-20210130","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/j.ajo.2004.04.058","article-title":"An evidence-based assessment of risk factors for the progression of ocular hypertension and glaucoma.","volume":"138","author":"Friedman","year":"2004","journal-title":"Am J Ophthalmol"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0b013e31816079e8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,12]],"date-time":"2021-09-12T22:02:32Z","timestamp":1631484152000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006982-200804000-00008"}},"subtitle":["Incidence and Risk Factors"],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0b013e31816079e8","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}